CA2778129C - Devices, systems and methods to treat heart failure - Google Patents
Devices, systems and methods to treat heart failure Download PDFInfo
- Publication number
- CA2778129C CA2778129C CA2778129A CA2778129A CA2778129C CA 2778129 C CA2778129 C CA 2778129C CA 2778129 A CA2778129 A CA 2778129A CA 2778129 A CA2778129 A CA 2778129A CA 2778129 C CA2778129 C CA 2778129C
- Authority
- CA
- Canada
- Prior art keywords
- flange
- core segment
- flange segments
- flow control
- control element
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract description 83
- 206010019280 Heart failures Diseases 0.000 title abstract description 18
- 210000005246 left atrium Anatomy 0.000 claims abstract description 38
- 210000005245 right atrium Anatomy 0.000 claims abstract description 37
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 9
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 abstract description 44
- 208000024891 symptom Diseases 0.000 abstract description 11
- 230000003073 embolic effect Effects 0.000 abstract description 10
- 230000001746 atrial effect Effects 0.000 abstract description 9
- 208000007536 Thrombosis Diseases 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 3
- 239000000306 component Substances 0.000 description 79
- 210000004971 interatrial septum Anatomy 0.000 description 48
- 238000005520 cutting process Methods 0.000 description 29
- 230000008569 process Effects 0.000 description 22
- 229920000642 polymer Polymers 0.000 description 15
- 239000007943 implant Substances 0.000 description 12
- 239000003550 marker Substances 0.000 description 11
- 230000006378 damage Effects 0.000 description 9
- 238000013022 venting Methods 0.000 description 9
- 206010007559 Cardiac failure congestive Diseases 0.000 description 8
- 208000003037 Diastolic Heart Failure Diseases 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 210000003157 atrial septum Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- -1 UHMPE Polymers 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 229910052719 titanium Inorganic materials 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 210000002837 heart atrium Anatomy 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 238000003466 welding Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000002594 fluoroscopy Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 210000002620 vena cava superior Anatomy 0.000 description 4
- 229920001651 Cyanoacrylate Polymers 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- 210000005240 left ventricle Anatomy 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000405070 Percophidae Species 0.000 description 2
- 229910001347 Stellite Inorganic materials 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000001765 aortic valve Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- AHICWQREWHDHHF-UHFFFAOYSA-N chromium;cobalt;iron;manganese;methane;molybdenum;nickel;silicon;tungsten Chemical compound C.[Si].[Cr].[Mn].[Fe].[Co].[Ni].[Mo].[W] AHICWQREWHDHHF-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002592 echocardiography Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000012858 resilient material Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 229910000014 Bismuth subcarbonate Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920004142 LEXAN™ Polymers 0.000 description 1
- 239000004418 Lexan Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- 206010039163 Right ventricular failure Diseases 0.000 description 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010071436 Systolic dysfunction Diseases 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 229920006355 Tefzel Polymers 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical class [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 229910001566 austenite Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 150000001621 bismuth Chemical class 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 description 1
- 229940036358 bismuth subcarbonate Drugs 0.000 description 1
- WMWLMWRWZQELOS-UHFFFAOYSA-N bismuth(III) oxide Inorganic materials O=[Bi]O[Bi]=O WMWLMWRWZQELOS-UHFFFAOYSA-N 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical compound C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 229910000734 martensite Inorganic materials 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002907 paramagnetic material Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009721 upset forging Methods 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2493—Transmyocardial revascularisation [TMR] devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2854571A CA2854571C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44761709A | 2009-04-28 | 2009-04-28 | |
| US12/447,617 | 2009-04-28 | ||
| US24008509P | 2009-09-04 | 2009-09-04 | |
| US61/240,085 | 2009-09-04 | ||
| CA2760207A CA2760207C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2760207A Division CA2760207C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2854571A Division CA2854571C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2778129A1 CA2778129A1 (en) | 2010-11-11 |
| CA2778129C true CA2778129C (en) | 2014-09-02 |
Family
ID=43050685
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2778129A Active CA2778129C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
| CA2760207A Active CA2760207C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2760207A Active CA2760207C (en) | 2009-04-28 | 2010-03-08 | Devices, systems and methods to treat heart failure |
Country Status (7)
| Country | Link |
|---|---|
| EP (3) | EP3146937B1 (OSRAM) |
| JP (3) | JP5002740B1 (OSRAM) |
| CN (3) | CN102908213B (OSRAM) |
| AU (1) | AU2010245215B9 (OSRAM) |
| CA (2) | CA2778129C (OSRAM) |
| IL (3) | IL215975A (OSRAM) |
| WO (1) | WO2010129089A2 (OSRAM) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8091556B2 (en) * | 2001-04-20 | 2012-01-10 | V-Wave Ltd. | Methods and apparatus for reducing localized circulatory system pressure |
| WO2005074367A2 (en) | 2004-02-03 | 2005-08-18 | Atria Medical Inc. | Device and method for controlling in-vivo pressure |
| WO2007083288A2 (en) | 2006-01-23 | 2007-07-26 | Atria Medical Inc. | Heart anchor device |
| US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
| JP2010508093A (ja) | 2006-11-07 | 2010-03-18 | セラマジャー，デイヴィッド，スティーヴン | 心不全を治療するための装置及び方法 |
| US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
| US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
| US12453626B2 (en) | 2009-05-04 | 2025-10-28 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
| US12186176B2 (en) | 2009-05-04 | 2025-01-07 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
| EP2427143B1 (en) | 2009-05-04 | 2017-08-02 | V-Wave Ltd. | Device for regulating pressure in a heart chamber |
| WO2011093941A2 (en) | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and systems for treating heart failure |
| AU2011210741B2 (en) | 2010-01-29 | 2013-08-15 | Corvia Medical, Inc. | Devices and methods for reducing venous pressure |
| AU2011223708A1 (en) * | 2010-03-01 | 2012-09-27 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| US9987153B2 (en) | 2010-06-08 | 2018-06-05 | The Regents Of The University Of Minnesota | Vascular elastance |
| JP5782523B2 (ja) | 2010-11-22 | 2015-09-24 | アリア シーブイ， インコーポレイテッド | 脈動圧力を減少させるためのシステムおよび方法 |
| CA2827025C (en) * | 2011-02-10 | 2020-09-01 | Dc Devices, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
| US9629715B2 (en) * | 2011-07-28 | 2017-04-25 | V-Wave Ltd. | Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same |
| US20130178784A1 (en) | 2011-12-22 | 2013-07-11 | Dc Devices, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
| US9005155B2 (en) | 2012-02-03 | 2015-04-14 | Dc Devices, Inc. | Devices and methods for treating heart failure |
| CN102764169B (zh) * | 2012-04-19 | 2015-07-29 | 杭州启明医疗器械有限公司 | 人工心脏瓣膜及其瓣膜支架 |
| US10588611B2 (en) | 2012-04-19 | 2020-03-17 | Corvia Medical Inc. | Implant retention attachment and method of use |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| US9649480B2 (en) | 2012-07-06 | 2017-05-16 | Corvia Medical, Inc. | Devices and methods of treating or ameliorating diastolic heart failure through pulmonary valve intervention |
| US9775636B2 (en) | 2013-03-12 | 2017-10-03 | Corvia Medical, Inc. | Devices, systems, and methods for treating heart failure |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| WO2014188279A2 (en) | 2013-05-21 | 2014-11-27 | V-Wave Ltd. | Apparatus and methods for delivering devices for reducing left atrial pressure |
| CA2914856C (en) * | 2013-06-25 | 2021-03-09 | Chad Perrin | Thrombus management and structural compliance features for prosthetic heart valves |
| US9775591B2 (en) * | 2013-11-21 | 2017-10-03 | Edwards Lifesciences Corporation | Sealing devices and related delivery apparatuses |
| US11712230B2 (en) * | 2014-05-02 | 2023-08-01 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
| US8876850B1 (en) | 2014-06-19 | 2014-11-04 | Aria Cv, Inc. | Systems and methods for treating pulmonary hypertension |
| EP3291773A4 (en) | 2015-05-07 | 2019-05-01 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | TEMPORARY INTERATRIAL SHUNTS |
| US9789294B2 (en) * | 2015-10-07 | 2017-10-17 | Edwards Lifesciences Corporation | Expandable cardiac shunt |
| DE202016008737U1 (de) | 2015-12-15 | 2019-04-05 | Neovasc Tiara Inc. | Transseptales Zuführsystem |
| JP7006940B2 (ja) | 2016-01-29 | 2022-01-24 | ニオバスク ティアラ インコーポレイテッド | 流出の閉塞を回避するための人工弁 |
| US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
| US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
| US12364480B2 (en) | 2016-07-25 | 2025-07-22 | Virender K. Sharma | Magnetic anastomosis device with opposing coil directionality |
| US11304698B2 (en) | 2016-07-25 | 2022-04-19 | Virender K. Sharma | Cardiac shunt device and delivery system |
| US10561423B2 (en) | 2016-07-25 | 2020-02-18 | Virender K. Sharma | Cardiac shunt device and delivery system |
| CN109788953B (zh) | 2016-07-25 | 2022-03-08 | 维兰德.K.沙马 | 磁性吻合装置和递送系统 |
| US11331105B2 (en) | 2016-10-19 | 2022-05-17 | Aria Cv, Inc. | Diffusion resistant implantable devices for reducing pulsatile pressure |
| CN109996581B (zh) | 2016-11-21 | 2021-10-15 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
| JP7033145B2 (ja) * | 2017-03-03 | 2022-03-09 | ブイ－ウェーブ リミテッド | 心房血液体積を再分配するためのシャント |
| US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
| WO2019015617A1 (zh) * | 2017-07-18 | 2019-01-24 | 杭州诺生医疗科技有限公司 | 一种适用于心房间的压力调节装置 |
| CN109259893B (zh) * | 2017-07-18 | 2025-12-12 | 杭州诺生医疗科技有限公司 | 一种心房间的压力调节装置 |
| US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| WO2019142152A1 (en) | 2018-01-20 | 2019-07-25 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
| US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
| US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
| US11717429B2 (en) * | 2018-09-19 | 2023-08-08 | Nxt Biomedical, Llc | Methods and technology for creating connections and shunts between vessels and chambers of biologic structures |
| JP7260930B2 (ja) | 2018-11-08 | 2023-04-19 | ニオバスク ティアラ インコーポレイテッド | 経カテーテル僧帽弁人工補綴物の心室展開 |
| CA3123613A1 (en) * | 2018-12-21 | 2020-06-25 | W. L. Gore & Associates, Inc. | Implantable cardiac sensors |
| US12357792B2 (en) | 2019-01-04 | 2025-07-15 | Shifamed Holdings, Llc | Internal recharging systems and methods of use |
| CA3132873C (en) | 2019-03-08 | 2024-07-02 | Neovasc Tiara Inc. | RECOVERABLE PROSTHESIS PLACEMENT SYSTEM |
| US11602429B2 (en) | 2019-04-01 | 2023-03-14 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
| US12226602B2 (en) | 2019-04-03 | 2025-02-18 | V-Wave Ltd. | Systems for delivering implantable devices across an atrial septum |
| US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
| US11491006B2 (en) | 2019-04-10 | 2022-11-08 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
| EP3972499A1 (en) | 2019-05-20 | 2022-03-30 | V-Wave Ltd. | Systems and methods for creating an interatrial shunt |
| CN114025813B (zh) | 2019-05-20 | 2024-05-14 | 内奥瓦斯克迪亚拉公司 | 具有止血机构的引入器 |
| CA3143344C (en) | 2019-06-20 | 2024-10-15 | Neovasc Tiara Inc. | LOW-PROFILE PROSTHETIC MITRAL VALVE |
| WO2021046252A1 (en) | 2019-09-06 | 2021-03-11 | Aria Cv, Inc. | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure |
| JP7648607B2 (ja) | 2019-09-09 | 2025-03-18 | シファメド・ホールディングス・エルエルシー | 調整可能なシャントならびに関連システム及び方法 |
| JP7525605B2 (ja) | 2019-12-05 | 2024-07-30 | シファメド・ホールディングス・エルエルシー | 植込み式シャントシステム及び方法 |
| EP4138981A4 (en) | 2020-04-23 | 2024-05-22 | Shifamed Holdings, LLC | Power management for interatrial shunts and associated systems and methods |
| WO2021217055A1 (en) | 2020-04-23 | 2021-10-28 | Shifamed Holdings, Llc | Intracardiac sensors with switchable configurations and associated systems and methods |
| WO2021216964A1 (en) | 2020-04-23 | 2021-10-28 | Shifamed Holdings, Llc | Systems and methods for radiographic monitoring of shunts |
| WO2021259136A1 (zh) * | 2020-06-23 | 2021-12-30 | 上海领闻医疗科技有限公司 | 一种心房间的压力调节装置 |
| EP4171397A1 (en) | 2020-06-25 | 2023-05-03 | Aria CV, Inc. | Implantable devices for reducing pulsatile pressure within a blood vessel |
| WO2022046921A1 (en) | 2020-08-25 | 2022-03-03 | Shifamed Holdings, Llc | Adjustable interatrial shunts and associated systems and methods |
| WO2022103973A1 (en) | 2020-11-12 | 2022-05-19 | Shifamed Holdings, Llc | Adjustable implantable devices and associated methods |
| US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
| WO2022192280A1 (en) | 2021-03-09 | 2022-09-15 | Shifamed Holdings, Llc | Shape memory actuators for adjustable shunting systems, and associated systems and methods |
| CA3247390A1 (en) | 2022-04-14 | 2023-10-19 | V-Wave Ltd. | EXTENDED INTERATRIAL SHUNT |
| US12296122B2 (en) | 2023-10-18 | 2025-05-13 | V-Wave Ltd. | Hybrid devices with dimensions that can be adjusted in vivo and methods of manufacturing thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
| ZA958860B (en) * | 1994-10-21 | 1997-04-18 | St Jude Medical | Rotatable cuff assembly for a heart valve prosthesis |
| IL117472A0 (en) * | 1996-03-13 | 1996-07-23 | Instent Israel Ltd | Radiopaque stent markers |
| US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
| US6790229B1 (en) * | 1999-05-25 | 2004-09-14 | Eric Berreklouw | Fixing device, in particular for fixing to vascular wall tissue |
| WO2005074367A2 (en) * | 2004-02-03 | 2005-08-18 | Atria Medical Inc. | Device and method for controlling in-vivo pressure |
| US8091556B2 (en) * | 2001-04-20 | 2012-01-10 | V-Wave Ltd. | Methods and apparatus for reducing localized circulatory system pressure |
| US7404824B1 (en) * | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
| US20040215323A1 (en) * | 2003-04-24 | 2004-10-28 | Medtronic Ave, Inc. | Membrane eyelet |
| US7317951B2 (en) * | 2003-07-25 | 2008-01-08 | Integrated Sensing Systems, Inc. | Anchor for medical implant placement and method of manufacture |
| CN101415452A (zh) * | 2004-02-03 | 2009-04-22 | 阿特里亚医学股份有限公司 | 用于控制体内压力的装置和方法 |
| US9039724B2 (en) * | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
| EP1849440A1 (en) * | 2006-04-28 | 2007-10-31 | Younes Boudjemline | Vascular stents with varying diameter |
| EP2023860A2 (en) * | 2006-04-29 | 2009-02-18 | Arbor Surgical Technologies, Inc. | Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them |
| JP2010508093A (ja) * | 2006-11-07 | 2010-03-18 | セラマジャー，デイヴィッド，スティーヴン | 心不全を治療するための装置及び方法 |
| SE530568C2 (sv) * | 2006-11-13 | 2008-07-08 | Medtentia Ab | Anordning och metod för förbättring av funktionen hos en hjärtklaff |
| EP2427143B1 (en) * | 2009-05-04 | 2017-08-02 | V-Wave Ltd. | Device for regulating pressure in a heart chamber |
-
2010
- 2010-03-08 CA CA2778129A patent/CA2778129C/en active Active
- 2010-03-08 AU AU2010245215A patent/AU2010245215B9/en active Active
- 2010-03-08 WO PCT/US2010/026574 patent/WO2010129089A2/en not_active Ceased
- 2010-03-08 JP JP2012508495A patent/JP5002740B1/ja active Active
- 2010-03-08 EP EP16184880.9A patent/EP3146937B1/en active Active
- 2010-03-08 CN CN201210175365.9A patent/CN102908213B/zh active Active
- 2010-03-08 CN CN201610025763.0A patent/CN105662653A/zh active Pending
- 2010-03-08 EP EP12180631.9A patent/EP2537490B1/en active Active
- 2010-03-08 CN CN2010800291276A patent/CN102458316A/zh active Pending
- 2010-03-08 CA CA2760207A patent/CA2760207C/en active Active
- 2010-03-08 EP EP10772411.4A patent/EP2424472B1/en active Active
-
2011
- 2011-10-27 IL IL215975A patent/IL215975A/en active IP Right Grant
-
2012
- 2012-05-21 JP JP2012115258A patent/JP5755180B2/ja active Active
- 2012-06-06 IL IL220201A patent/IL220201A/en active IP Right Grant
-
2015
- 2015-05-26 JP JP2015106477A patent/JP6211034B2/ja active Active
-
2017
- 2017-07-25 IL IL253648A patent/IL253648B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010129089A4 (en) | 2011-03-10 |
| JP6211034B2 (ja) | 2017-10-11 |
| CN102458316A (zh) | 2012-05-16 |
| CN105662653A (zh) | 2016-06-15 |
| IL220201A (en) | 2017-08-31 |
| AU2010245215A1 (en) | 2011-12-08 |
| IL220201A0 (en) | 2012-07-31 |
| IL215975A0 (en) | 2012-01-31 |
| CA2760207A1 (en) | 2010-11-11 |
| IL253648A0 (en) | 2017-09-28 |
| AU2010245215B9 (en) | 2013-11-07 |
| EP2424472A2 (en) | 2012-03-07 |
| CN102908213A (zh) | 2013-02-06 |
| IL215975A (en) | 2016-11-30 |
| EP3146937A1 (en) | 2017-03-29 |
| IL253648B (en) | 2021-04-29 |
| EP2424472B1 (en) | 2015-12-23 |
| WO2010129089A3 (en) | 2011-01-13 |
| AU2010245215B2 (en) | 2013-09-12 |
| JP2012179388A (ja) | 2012-09-20 |
| CA2760207C (en) | 2014-08-12 |
| JP5002740B1 (ja) | 2012-08-15 |
| EP2424472A4 (en) | 2012-04-18 |
| EP2537490B1 (en) | 2016-08-24 |
| EP3146937B1 (en) | 2019-10-02 |
| JP5755180B2 (ja) | 2015-07-29 |
| EP2537490A1 (en) | 2012-12-26 |
| CN102908213B (zh) | 2015-05-13 |
| JP2012525210A (ja) | 2012-10-22 |
| CA2778129A1 (en) | 2010-11-11 |
| JP2015165934A (ja) | 2015-09-24 |
| WO2010129089A2 (en) | 2010-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2778129C (en) | Devices, systems and methods to treat heart failure | |
| US8157860B2 (en) | Devices, systems and methods to treat heart failure | |
| US20220313234A1 (en) | Intra-atrial implants made of non-braided material | |
| CA2998009C (en) | Devices, systems and methods to treat heart failure | |
| AU2012202952B2 (en) | Devices, Systems And Methods To Treat Heart Failure | |
| HK1167079A (en) | Devices, systems and methods to treat heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |